InsiderTrades.com logo

LGND Insider Trading

Insider Ownership Percentage: 7.00%
Insider Buying (Last 12 Months): $1,156,542.00
Insider Selling (Last 12 Months): $10,415,711.56

Ligand Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Ligand Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Ligand Pharmaceuticals Share Price & Price History

Current Price: $213.64
Price Change: ▲ Price Increase of +3.305 (1.57%)
As of 05/8/2026 11:25 AM ET

This chart shows the closing price history over time for LGND up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Ligand Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/1/2026Andrew ReardonInsiderSell5,000$231.31$1,156,550.0041,382View SEC Filing Icon  
4/1/2026Andrew ReardonInsiderSell5,000$201.24$1,006,200.0041,382View SEC Filing Icon  
4/1/2026John W. KozarichDirectorSell467$202.23$94,441.4142,253View SEC Filing Icon  
3/23/2026Stephen L. SabbaDirectorSell1,000$207.87$207,870.0032,793View SEC Filing Icon  
3/11/2026Octavio EspinozaCFOSell3,057$225.00$687,825.0021,010View SEC Filing Icon  
3/4/2026Andrew ReardonInsiderSell5,000$206.35$1,031,750.0036,869View SEC Filing Icon  
3/4/2026Octavio EspinozaCFOSell13,423$205.83$2,762,856.0921,662View SEC Filing Icon  
3/3/2026Stephen L. SabbaDirectorSell2,034$201.50$409,851.0033,793View SEC Filing Icon  
3/2/2026John W. KozarichDirectorSell467$200.50$93,633.5042,720View SEC Filing Icon  
2/2/2026John W. KozarichDirectorSell467$195.91$91,489.9743,187View SEC Filing Icon  
1/2/2026John W. KozarichDirectorSell467$189.58$88,533.8643,654View SEC Filing Icon  
12/12/2025Octavio EspinozaCFOSell1,804$188.31$339,711.2426,186View SEC Filing Icon  
12/1/2025John W. KozarichDirectorSell467$195.84$91,457.2844,121View SEC Filing Icon  
11/3/2025John W. KozarichDirectorSell467$191.05$89,220.3544,588View SEC Filing Icon  
10/1/2025John W. KozarichDirectorSell467$179.44$83,798.4845,055View SEC Filing Icon  
9/23/2025Jason AryehDirectorSell10,000$170.81$1,708,100.0069,289View SEC Filing Icon  
9/2/2025John W. KozarichDirectorSell467$162.26$75,775.4245,522View SEC Filing Icon  
8/1/2025John W. KozarichDirectorSell467$131.88$61,587.9645,989View SEC Filing Icon  
7/10/2025John W. KozarichDirectorSell934$125.00$116,750.0046,456View SEC Filing Icon  
6/23/2025Andrew ReardonInsiderSell500$114.08$57,040.0031,903View SEC Filing Icon  
6/10/2025Andrew ReardonInsiderSell500$114.54$57,270.0032,403View SEC Filing Icon  
5/15/2025Andrew ReardonInsiderSell1,000$104.00$104,000.0032,903View SEC Filing Icon  
5/9/2025Octavio EspinozaCFOBuy1,500$104.06$156,090.0027,932View SEC Filing Icon  
5/9/2025Todd C. DavisCEOBuy9,510$105.20$1,000,452.00161,234View SEC Filing Icon  
3/4/2025Octavio EspinozaCFOSell5,000$115.03$575,150.0018,879View SEC Filing Icon  
12/23/2024Octavio EspinozaCFOSell2,104$116.37$244,842.4820,647View SEC Filing Icon  
11/27/2024John L. LaMattinaDirectorSell2,406$123.65$297,501.9029,515View SEC Filing Icon  
9/23/2024Andrew ReardonInsiderSell2,000$99.60$199,200.0022,534View SEC Filing Icon  
9/23/2024Matthew E KorenbergCOOSell9,772$101.22$989,121.8450,777View SEC Filing Icon  
9/20/2024Matthew E KorenbergCOOSell6,275$104.10$653,227.5050,777View SEC Filing Icon  
9/20/2024Octavio EspinozaCFOSell1,275$103.94$132,523.5024,610View SEC Filing Icon  
8/28/2024Andrew ReardonInsiderSell1,500$106.39$159,585.0022,534View SEC Filing Icon  
8/26/2024Matthew E KorenbergCOOSell11,389$105.61$1,202,792.2949,510View SEC Filing Icon  
8/22/2024Matthew E KorenbergCOOSell1,157$105.54$122,109.7867,211View SEC Filing Icon  
8/9/2024Matthew E KorenbergCOOSell18,245$98.50$1,797,132.5068,368View SEC Filing Icon  
8/8/2024Todd C. DavisCEOBuy2,500$97.39$243,475.00123,010View SEC Filing Icon  
5/17/2024Octavio EspinozaCFOSell5,156$86.66$446,818.9623,379View SEC Filing Icon  
5/15/2024Octavio EspinozaCFOSell5,873$86.01$505,136.7323,882View SEC Filing Icon  
5/13/2024Matthew E KorenbergInsiderSell3,440$84.54$290,817.60100,421View SEC Filing Icon  
5/9/2024Andrew ReardonInsiderSell10,000$83.04$830,400.0022,205View SEC Filing Icon  
5/9/2024Nancy Ryan GrayDirectorSell934$83.20$77,708.805,633View SEC Filing Icon  
3/5/2024Stephen L. SabbaDirectorSell1,893$74.30$140,649.9028,926View SEC Filing Icon  
2/28/2024Octavio EspinozaCFOSell140$88.46$12,384.4029,755View SEC Filing Icon  
9/22/2023Todd C. DavisCEOBuy4,000$59.38$237,520.0073,090View SEC Filing Icon  
5/16/2023John W. KozarichDirectorSell4,444$77.20$343,076.8038,488View SEC Filing Icon  
5/10/2023Stephen L. SabbaDirectorSell6,408$77.13$494,249.0425,784View SEC Filing Icon  
5/8/2023John W. KozarichDirectorSell6,408$76.56$490,596.4842,213View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Ligand Pharmaceuticals (NASDAQ:LGND)

91.28% of Ligand Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at LGND by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Ligand Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/8/2026PNC Financial Services Group Inc.2,342$0.47M0.0%+4.6%0.012%Search for SEC Filing on Google Icon
5/8/2026Summit Global Investments1,937$0.39M0.0%-19.9%0.010%Search for SEC Filing on Google Icon
5/7/2026WCM Investment Management LLC44,658$8.60M0.0%-2.1%0.223%Search for SEC Filing on Google Icon
5/7/2026Dimensional Fund Advisors LP425,230$84.89M0.0%-1.8%2.122%Search for SEC Filing on Google Icon
5/7/2026Swiss National Bank38,900$7.77M0.0%+0.8%0.194%Search for SEC Filing on Google Icon
5/6/2026Future Fund LLC13,840$2.76M1.0%+49.1%0.069%Search for SEC Filing on Google Icon
5/6/2026Assetmark Inc.6,570$1.31M0.0%+6.1%0.033%Search for SEC Filing on Google Icon
5/6/2026Bessemer Group Inc.107,859$21.54M0.0%+358.8%0.538%Search for SEC Filing on Google Icon
5/6/2026Allspring Global Investments Holdings LLC52,652$10.51M0.0%-26.7%0.263%Search for SEC Filing on Google Icon
5/5/2026Bank of New York Mellon Corp119,403$23.84M0.0%-2.3%0.596%Search for SEC Filing on Google Icon
5/5/2026Illinois Municipal Retirement Fund8,961$1.79M0.0%-23.5%0.045%Search for SEC Filing on Google Icon
5/5/2026Sigma Planning Corp4,500$0.90M0.0%+50.0%0.022%Search for SEC Filing on Google Icon
5/5/2026Hillsdale Investment Management Inc.1,540$0.31M0.0%+3,750.0%0.008%Search for SEC Filing on Google Icon
5/4/2026Calamos Advisors LLC20,860$4.17M0.0%-0.9%0.104%Search for SEC Filing on Google Icon
5/4/2026Principal Financial Group Inc.95,716$19.11M0.0%+2.0%0.478%Search for SEC Filing on Google Icon
5/1/2026Fifth Third Bancorp5,501$1.10M0.0%+3,519.1%0.027%Search for SEC Filing on Google Icon
5/1/2026Sequoia Financial Advisors LLC1,204$0.24M0.0%N/A0.006%Search for SEC Filing on Google Icon
5/1/2026Villere ST Denis J & Co. LLC188,874$37.71M4.2%-6.7%0.942%Search for SEC Filing on Google Icon
4/30/2026Hsbc Holdings PLC3,455$0.69M0.0%N/A0.017%Search for SEC Filing on Google Icon
4/30/2026Granite Investment Partners LLC54,155$10.81M0.7%-6.5%0.270%Search for SEC Filing on Google Icon
4/30/2026Isthmus Partners LLC24,059$4.80M0.5%-2.6%0.120%Search for SEC Filing on Google Icon
4/28/2026Abel Hall LLC1,112$0.22M0.0%N/A0.006%Search for SEC Filing on Google Icon
4/28/2026Stephens Investment Management Group LLC494,670$98.76M1.4%-1.3%2.469%Search for SEC Filing on Google Icon
4/27/2026Moran Wealth Management LLC19,306$3.85M0.1%N/A0.096%Search for SEC Filing on Google Icon
4/27/2026New York State Teachers Retirement System24,509$4.89M0.0%-9.1%0.122%Search for SEC Filing on Google Icon
4/25/2026Strs Ohio5,800$1.16M0.0%-4.9%0.029%Search for SEC Filing on Google Icon
4/25/2026Keybank National Association OH1,874$0.37M0.0%+26.9%0.009%Search for SEC Filing on Google Icon
4/23/2026Inspire Investing LLC909$0.18M0.0%N/A0.005%Search for SEC Filing on Google Icon
4/22/20261492 Capital Management LLC1,958$0.39M0.1%+4.4%0.010%Search for SEC Filing on Google Icon
4/22/2026Pictet Asset Management Holding SA60,737$11.72M0.0%-5.7%0.305%Search for SEC Filing on Google Icon
4/21/2026Louisiana State Employees Retirement System8,700$1.74M0.0%N/A0.044%Search for SEC Filing on Google Icon
4/20/2026BTC Capital Management Inc.2,390$0.48M0.0%+11.5%0.012%Search for SEC Filing on Google Icon
4/20/2026RFG Advisory LLC2,544$0.51M0.0%N/A0.013%Search for SEC Filing on Google Icon
4/16/2026SG Americas Securities LLC1,416$0.28M0.0%-86.9%0.007%Search for SEC Filing on Google Icon
4/16/2026CWC Advisors LLC.3,389$0.68M0.3%-4.0%0.017%Search for SEC Filing on Google Icon
3/9/2026Corient Private Wealth LLC3,561$0.67M0.0%+26.3%0.018%Search for SEC Filing on Google Icon
2/26/2026Alpine Global Management LLC1,500$0.28M0.0%N/A0.008%Search for SEC Filing on Google Icon
2/19/2026Invesco Ltd.516,464$97.65M0.0%+36.5%2.624%Search for SEC Filing on Google Icon
2/19/2026Corient Private Wealth LLC12,388$2.34M0.0%+339.3%0.063%Search for SEC Filing on Google Icon
2/18/2026Summit Global Investments2,417$0.46M0.0%+67.6%0.012%Search for SEC Filing on Google Icon
2/18/2026State of Tennessee Department of Treasury5,119$0.98M0.0%-34.3%0.026%Search for SEC Filing on Google Icon
2/18/2026XTX Topco Ltd7,717$1.46M0.0%N/A0.039%Search for SEC Filing on Google Icon
2/18/2026Uniplan Investment Counsel Inc.40,493$7.66M2.2%-4.0%0.206%Search for SEC Filing on Google Icon
2/18/2026Voloridge Investment Management LLC12,038$2.28M0.0%+40.0%0.061%Search for SEC Filing on Google Icon
2/18/2026Virtus Investment Advisers LLC3,605$0.68M0.2%-7.2%0.018%Search for SEC Filing on Google Icon
2/18/2026Wellington Management Group LLP8,426$1.59M0.0%+1.3%0.043%Search for SEC Filing on Google Icon
2/18/2026Susquehanna Portfolio Strategies LLC7,744$1.46M0.0%+33.6%0.039%Search for SEC Filing on Google Icon
2/18/2026Private Capital Management LLC208,891$39.50M3.6%-8.0%1.061%Search for SEC Filing on Google Icon
2/18/2026Man Group plc3,450$0.65M0.0%N/A0.018%Search for SEC Filing on Google Icon
2/18/2026Janus Henderson Group PLC995,400$188.20M0.1%-4.5%5.058%Search for SEC Filing on Google Icon
2/18/2026Gotham Asset Management LLC9,346$1.77M0.0%-1.4%0.047%Search for SEC Filing on Google Icon
2/17/2026Freestone Grove Partners LP2,867$0.54M0.0%N/A0.015%Search for SEC Filing on Google Icon
2/17/2026Guggenheim Capital LLC5,257$0.99M0.0%N/A0.027%Search for SEC Filing on Google Icon
2/17/2026AQR Capital Management LLC5,158$0.98M0.0%+12.5%0.026%Search for SEC Filing on Google Icon
2/17/2026Cetera Investment Advisers3,335$0.63M0.0%+111.6%0.017%Search for SEC Filing on Google Icon
2/17/2026Equitable Holdings Inc.9,605$1.82M0.0%+8.7%0.049%Search for SEC Filing on Google Icon
2/17/2026Trexquant Investment LP11,550$2.18M0.0%-74.0%0.059%Search for SEC Filing on Google Icon
2/17/2026Amundi3,033$0.57M0.0%-9.6%0.015%Search for SEC Filing on Google Icon
2/17/2026Price T Rowe Associates Inc. MD19,992$3.78M0.0%+5.7%0.102%Search for SEC Filing on Google Icon
2/17/2026Osaic Holdings Inc.59,405$11.23M0.0%-41.0%0.302%Search for SEC Filing on Google Icon
2/17/2026California State Teachers Retirement System18,797$3.55M0.0%+2.7%0.096%Search for SEC Filing on Google Icon
2/17/2026Diadema Partners LP2,987$0.57M0.1%N/A0.015%Search for SEC Filing on Google Icon
2/17/2026Russell Investments Group Ltd.138,464$26.18M0.0%+1.7%0.704%Search for SEC Filing on Google Icon
2/17/2026Maryland State Retirement & Pension System2,872$0.54M0.0%+2.2%0.015%Search for SEC Filing on Google Icon
2/17/2026Clark Capital Management Group Inc.79,778$15.08M0.1%-3.9%0.405%Search for SEC Filing on Google Icon
2/17/2026Granahan Investment Management LLC26,050$4.93M0.2%+4.4%0.132%Search for SEC Filing on Google Icon
2/17/2026State of Wisconsin Investment Board11,155$2.11M0.0%-2.0%0.057%Search for SEC Filing on Google Icon
2/17/2026Captrust Financial Advisors14,579$2.76M0.0%-2.9%0.074%Search for SEC Filing on Google Icon
2/17/2026Fred Alger Management LLC3,762$0.71M0.0%-35.9%0.019%Search for SEC Filing on Google Icon
2/17/2026Ashford Capital Management Inc.213,778$40.42M4.5%-12.5%1.086%Search for SEC Filing on Google Icon
2/17/2026Blair William & Co. IL8,474$1.60M0.0%+1.0%0.043%Search for SEC Filing on Google Icon
2/17/2026Royal Bank of Canada108,796$20.57M0.0%+5.1%0.553%Search for SEC Filing on Google Icon
2/17/2026Persistent Asset Partners Ltd791$0.15M0.1%N/A0.004%Search for SEC Filing on Google Icon
2/17/2026Rice Hall James & Associates LLC279,627$52.87M2.9%-5.0%1.421%Search for SEC Filing on Google Icon
2/16/2026MML Investors Services LLC3,734$0.71M0.0%-5.8%0.019%Search for SEC Filing on Google Icon
2/16/2026NFJ Investment Group LLC12,291$2.32M0.1%-4.3%0.062%Search for SEC Filing on Google Icon
2/16/2026Barclays PLC32,982$6.24M0.0%+8.9%0.168%Search for SEC Filing on Google Icon
2/13/2026Kestra Advisory Services LLC166$31K0.0%N/A0.001%Search for SEC Filing on Google Icon
2/13/2026FORA Capital LLC1,922$0.34M0.0%N/A0.010%Search for SEC Filing on Google Icon
2/13/2026The Manufacturers Life Insurance Company 9,111$1.72M0.0%-4.6%0.046%Search for SEC Filing on Google Icon
2/13/2026CANADA LIFE ASSURANCE Co16,750$3.16M0.0%-28.1%0.085%Search for SEC Filing on Google Icon
2/13/2026Bridgewater Associates LP4,207$0.80M0.0%+226.6%0.021%Search for SEC Filing on Google Icon
2/13/2026Stifel Financial Corp18,722$3.54M0.0%-8.7%0.095%Search for SEC Filing on Google Icon
2/13/2026Commerce Bank1,308$0.25M0.0%N/A0.007%Search for SEC Filing on Google Icon
2/13/2026Jacobs Levy Equity Management Inc.126,754$23.97M0.1%-0.7%0.644%Search for SEC Filing on Google Icon
2/13/2026Public Sector Pension Investment Board68,114$12.88M0.0%-10.9%0.346%Search for SEC Filing on Google Icon
2/13/2026Essex Investment Management Co. LLC60,020$11.35M1.7%-1.8%0.305%Search for SEC Filing on Google Icon
2/13/2026First Trust Advisors LP69,220$13.09M0.0%+33.9%0.352%Search for SEC Filing on Google Icon
2/13/2026Charles Schwab Investment Management Inc.184,284$34.84M0.0%+1.1%0.936%Search for SEC Filing on Google Icon
2/13/2026State Street Corp751,205$142.03M0.0%+0.2%3.817%Search for SEC Filing on Google Icon
2/13/2026Victory Capital Management Inc.256,410$48.48M0.0%+0.6%1.303%Search for SEC Filing on Google Icon
2/13/2026Martingale Asset Management L P15,322$2.90M0.1%-17.1%0.078%Search for SEC Filing on Google Icon
2/13/2026Dynamic Technology Lab Private Ltd1,130$0.21M0.0%N/A0.006%Search for SEC Filing on Google Icon
2/13/2026UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC363,584$68.74M0.0%-3.5%1.847%Search for SEC Filing on Google Icon
2/13/2026Wells Fargo & Company MN132,636$25.08M0.0%+15.2%0.674%Search for SEC Filing on Google Icon
2/13/2026Castleark Management LLC66,736$12.62M0.4%+3.2%0.339%Search for SEC Filing on Google Icon
2/12/2026Advisors Asset Management Inc.3,336$0.63M0.0%-2.0%0.017%Search for SEC Filing on Google Icon
2/12/2026Orion Porfolio Solutions LLC3,501$0.66M0.0%+195.2%0.018%Search for SEC Filing on Google Icon
2/12/2026MetLife Investment Management LLC10,655$2.02M0.0%-3.9%0.054%Search for SEC Filing on Google Icon
2/12/2026Cibc World Markets Corp1,283$0.24M0.0%N/A0.007%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Ligand Pharmaceuticals logo
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, engages in the development and licensing of biopharmaceutical assets worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Rylaze, a recombinant erwinia asparaginase for the treatment of acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; Filspari, a dual endothelin and angiotensin II receptor antagonist in development for rare kidney diseases and non-immunosuppressive treatment indicated for immunoglobulin A nephropathy; Teriparatide injection product for osteoporosis; Vaxneuvance for the prevention of invasive disease caused by streptococcus pneumoniae serotypes; and Pneumosil, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia among children. The company also offers TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes (T1D) in adults and children aged 8 years and older with Stage 2 T1D; Nexterone, a captisol-enabled formulation of amiodarone; Zulresso, a captisol-enabled formulation of brexanolone for the treatment of postpartum depression; and Veklury, an antiviral treatment for moderate or severe COVID-19. In addition, it provides Noxafil-IV, a captisol-enabled formulation of posaconazole for IV use; Duavee for the treatment of post-menopausal symptoms in women; Exemptia for autoimmune diseases; Vivitra for breast cancer; and Bryxta and Zybev for various indications. The company has alliances, licenses, and other business relationships with Amgen, Merck, Pfizer, Jazz, Takeda, Gilead Sciences, and Baxter International. Further, it sells Captisol materials. Ligand Pharmaceuticals Incorporated was incorporated in 1987 and is based in Jupiter, Florida.
Read More on Ligand Pharmaceuticals

Today's Range

Now: $213.64
Low: $206.02
High: $215.90

50 Day Range

MA: $212.17
Low: $191.39
High: $241.79

52 Week Range

Now: $213.64
Low: $98.89
High: $247.38

Volume

44,540 shs

Average Volume

225,509 shs

Market Capitalization

$4.28 billion

P/E Ratio

36.63

Dividend Yield

N/A

Beta

1.2

Who are the company insiders with the largest holdings of Ligand Pharmaceuticals?

Ligand Pharmaceuticals' top insider investors include:
  1. John L Higgins (Director)
  2. John L Higgins (CEO)
  3. Matthew W Foehr (COO)
  4. Todd C Davis (CEO)
  5. John Higgins (CEO)
  6. Matthew W Foehr (Insider)
  7. Matthew E Korenberg (Insider)
  8. Jason Aryeh (Director)
  9. Matthew E Korenberg (COO)
  10. Todd C Davis (Director)
Learn More about top insider investors at Ligand Pharmaceuticals.

Who are the major institutional investors of Ligand Pharmaceuticals?

Ligand Pharmaceuticals' top institutional investors include:
  1. Stephens Investment Management Group LLC — 2.47%
  2. Villere ST Denis J & Co. LLC — 0.94%
  3. Bank of New York Mellon Corp — 0.60%
  4. Bessemer Group Inc. — 0.54%
  5. Principal Financial Group Inc. — 0.48%
  6. Pictet Asset Management Holding SA — 0.30%
Learn More about top institutional investors of Ligand Pharmaceuticals stock.

Which institutional investors are selling Ligand Pharmaceuticals stock?

In the previous quarter, LGND stock was sold by these institutional investors:
  1. Allspring Global Investments Holdings LLC
  2. Villere ST Denis J & Co. LLC
  3. SG Americas Securities LLC
  4. Stephens Investment Management Group LLC
  5. Granite Investment Partners LLC
  6. Pictet Asset Management Holding SA
  7. Bank of New York Mellon Corp
  8. Illinois Municipal Retirement Fund
During the previous year, company insiders that have sold Ligand Pharmaceuticals company stock include:
  1. Jason Aryeh (Director)
  2. John W Kozarich (Director)
  3. Andrew Reardon (Insider)
  4. Stephen L Sabba (Director)
  5. Octavio Espinoza (CFO)
Learn More investors selling Ligand Pharmaceuticals stock.

Which institutional investors are buying Ligand Pharmaceuticals stock?

During the previous quarter, LGND stock was acquired by institutional investors including:
  1. Bessemer Group Inc.
  2. Moran Wealth Management LLC
  3. Louisiana State Employees Retirement System
  4. Fifth Third Bancorp
  5. Future Fund LLC
  6. Hsbc Holdings PLC
  7. RFG Advisory LLC
  8. Principal Financial Group Inc.
Within the last year, these company insiders have bought Ligand Pharmaceuticals stock:
  1. Todd C Davis (CEO)
  2. Octavio Espinoza (CFO)
Learn More investors buying Ligand Pharmaceuticals stock.

Ligand Pharmaceuticals Active Insiders

John L Higgins
John L Higgins (Age 56)
CEO
Todd C Davis
Todd C Davis
CEO
Matthew W Foehr
Matthew W Foehr (Age 53)
COO
Octavio Espinoza
Octavio Espinoza
CFO
3 recent trades
John L Lamattina
John L Lamattina
Director
John W Kozarich
John W Kozarich
Director
5 recent trades
Nancy Ryan Gray
Nancy Ryan Gray
Director
Stephen L Sabba
Stephen L Sabba
Director
2 recent trades
Andrew Reardon
Andrew Reardon
Chief Legal Officer
3 recent trades